ResMed Inc. (ASX:RMD)

ResMed Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 17, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	57,853	42,141	48,280	44,545	47,888	40,231
Market Cap Growth	17.95%	-12.72%	8.38%	-6.98%	19.03%	61.21%
Enterprise Value	57,692	43,502	50,510	45,434	48,707	41,903
Last Close Price	39.81	28.84	32.17	29.33	31.11	25.95
PE Ratio	27.47	27.54	35.80	39.38	75.67	44.68
PS Ratio	7.19	6.00	7.61	8.58	11.23	9.39
PB Ratio	6.51	5.78	7.78	9.13	12.44	11.12
P/TBV Ratio	15.92	18.30	39.81	28.46	63.52	175.21
P/FCF Ratio	-	21.60	56.02	141.88	56.63	39.29
P/OCF Ratio	-	20.07	46.35	87.40	48.73	34.62
EV/Sales Ratio	7.50	6.20	7.96	8.75	11.42	9.78
EV/EBITDA Ratio	20.75	18.93	26.02	27.80	35.49	31.35
EV/EBIT Ratio	23.31	20.97	29.18	31.24	39.80	35.76
EV/FCF Ratio	22.94	22.30	58.60	144.71	57.60	40.92
Debt / Equity Ratio	0.15	0.18	0.38	0.27	0.28	0.52
Debt / EBITDA Ratio	0.46	0.56	1.19	0.79	0.75	1.37
Debt / FCF Ratio	0.54	0.67	2.75	4.24	1.25	1.84
Asset Turnover	0.70	0.69	0.71	0.73	0.69	0.68
Inventory Turnover	2.09	1.87	1.84	2.30	2.97	3.10
Quick Ratio	2.06	1.18	1.23	1.28	1.01	1.57
Current Ratio	3.41	2.59	3.12	2.80	1.73	2.53
Return on Equity (ROE)	25.81%	22.70%	23.96%	24.96%	17.63%	27.21%
Return on Assets (ROA)	14.01%	12.70%	12.15%	12.75%	12.31%	11.63%
Return on Capital (ROIC)	16.54%	15.11%	14.42%	15.74%	15.34%	14.17%
Return on Capital Employed (ROCE)	24.30%	23.20%	19.20%	22.70%	24.00%	20.30%
Earnings Yield	3.64%	3.63%	2.79%	2.54%	1.32%	2.24%
FCF Yield	4.35%	4.63%	1.79%	0.70%	1.77%	2.54%
Dividend Yield	1.22%	9.98%	8.22%	8.31%	6.82%	8.71%
Payout Ratio	23.14%	27.65%	28.78%	31.48%	47.78%	36.21%
Buyback Yield / Dilution	0.07%	-0.06%	-0.28%	-0.40%	-0.55%	-0.81%
Total Shareholder Return	1.29%	9.91%	7.94%	7.91%	6.27%	7.90%

Updated Jan 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.